COPD: Page 3

Improving inhalers for COPD patients
Researchers are using computer modeling combined with particle and pharmaceutical sciences to create a better inhaler.
August 19, 2026
Black 3D printed mechanical parts with yellow stripe detail in workshop setting
Link found between mental health, COPD
Scientists determine breathlessness caused by COPD breeds vulnerable mental health state.
August 19, 2026
Thoughtful woman sitting on a couch in a modern living room, hand near her face in a contemplative pose.
AI detects myosteatosis as strong COPD risk predictor
Analysis found CT-derived muscle quality predicts COPD better than emphysema lung measures.
August 13, 2026
Healthcare professional assisting patient during CT or MRI scan procedure in medical imaging facility
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Azithromycin vs. roflumilast for COPD
Researchers from UCLA compared the two treatments to provide insights that help guide patient care.
August 13, 2026
Healthcare professional in blue scrubs showing tablet to smiling patient in medical office setting
Company seeks to expand use of AI-based COPD diagnostic tool
The N-Tidal Diagnose provides an alternative to traditional spirometry using AI algorithms.
August 6, 2026
White and purple handheld medical scanner device displayed with geometric blue and white props on gradient background
Study to examine novel test for COPD exacerbations
Clinical study aims to evaluate the diagnostic potential of a lateral flow test for active neutrophil elastase.
August 6, 2026
NEATstik Neutrophil Elastase Airways Test kit box by ProAxsis for research use
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Beta blockers show no additional risk after myocardial infarction in COPD patients
Research finds that beta-blocker use after a first-time MI was associated with a lower mortality in patients who have COPD with no increased risk.
July 29, 2026
Anatomical illustration of a glowing human heart with ECG heartbeat waveform and torso silhouette on blue background
Light physical activity can help patients with COPD live longer
Study finds that physical activity doesn’t have to be strenuous to make a difference.
July 29, 2026
Woman in bright yellow shirt smiling in sunlit tree-lined garden pathway
Usage of COPD treatment options lower among Black population
Research highlights inequities in COPD care among minority groups.
July 21, 2026
Person in white shirt with hand on chest expressing concern or emotion
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Virtual reality could help ease anxiety and depression in COPD patients
In-depth analysis suggests the technology may serve as a valuable addition to pulmonary rehabilitation.
July 21, 2026
Woman wearing VR headset gestures while colleague holds tablet in modern office setting
Trial to examine treatment for COPD-related muscle loss
The novel, first-in-class therapy targets an area where no approved pharmacological treatments currently exist.
July 15, 2026
Medical comparison diagram showing sarcopenia with atrophied muscle versus normal healthy muscle tissue in cross-section.
Cognitive, physical limitations shown to impact COPD inhaler use
Researchers associate mental impairment and nonfunctional manual dexterity to inhaler misuse and recommend comprehensive education.
July 15, 2026
Middle-aged man using inhaler while sitting on bed, holding chest in discomfort
Previous Page
Page 3 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial